Evidence map›Paper›PMID 33390155›Full record

ArticleBMC medicine2021

Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score.

Krasimira Aleksandrova, Robin Reichmann, Rudolf Kaaks, Mazda Jenab, H Bas Bueno-de-Mesquita, Christina C Dahm, Anne Kirstine Eriksen, Anne Tjønneland, Fanny Artaud, Marie-Christine Boutron-Ruault and 32 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Risk Association of Liver Cancer and Hepatitis B with Tree Ensemble and Lifestyle Features.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 10 countries.

Krasimira AleksandrovaNutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany. aleksandrova@leibniz-bips.de.
Robin ReichmannNutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mazda JenabInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
H Bas Bueno-de-MesquitaNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Anne Kirstine EriksenDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Fanny ArtaudCESP, Faculté de Medicine, Université Paris-Saclay, Villejuif, France.
Marie-Christine Boutron-RuaultCESP, Faculté de Medicine, Université Paris-Saclay, Villejuif, France.
Gianluca SeveriCESP, Faculté de Medicine, Université Paris-Saclay, Villejuif, France.
Anika HüsingDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Eleni PeppaHellenic Health Foundation, Athens, Greece.
Salvatore PanicoEPIC Centre of Naples, Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, Naples, Italy.
Giovanna MasalaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy.
Sjoerd G EliasJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Kristin B BorchDepartment of Community Medicine, Health Faculty, UiT-the Arctic university of Norway, Tromsø, Norway.
Torkjel M SandangerDepartment of Community Medicine, Health Faculty, UiT-the Arctic university of Norway, Tromsø, Norway.
Guri SkeieDepartment of Community Medicine, Health Faculty, UiT-the Arctic university of Norway, Tromsø, Norway.
Maria-Jose SánchezEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
José María HuertaCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Núria SalaUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Translational Research Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain.
Aurelio Barricarte GurreaCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
José Ramón QuirósPublic Health Directorate, Asturias, Spain.
Pilar AmianoCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Jonna BerntssonDepartment of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
Isabel DrakeDepartment of Clinical Sciences in Malmö, Lund University, Lund, Sweden.
Bethany van GuelpenDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Sophia HarlidDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Tim KeyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Elom K AglagoInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Marc J GunterInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Centre International de Recherche sur le Cancer · FRImperial College London · GBHellenic Health Foundation · GRUiT The Arctic University of Norway · NOCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKInstitut Gustave Roussy · FRLund University · SEUmeå University · SEAarhus University · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESHeidelberg University · DEInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Investigación Biosanitaria de Granada · ESInstituto de Salud Pública de Navarra · ESPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversité Paris-Saclay · FR

Funding

Cancer Research UK 14136Cancer Research UK 25004Cancer Research UK C8221/A19170Cancer Research UK C864/A14136Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC-UU_12015/1Medical Research Council MC_UU_12015/1Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

backgroundNutrition and lifestyle have been long established as risk factors for colorectal cancer (CRC). Modifiable lifestyle behaviours bear potential to minimize long-term CRC risk; however, translation of lifestyle information into individualized CRC risk assessment has not been implemented. Lifestyle-based risk models may aid the identification of high-risk individuals, guide referral to screening and motivate behaviour change. We therefore developed and validated a lifestyle-based CRC risk prediction algorithm in an asymptomatic European population.

methodsThe model was based on data from 255,482 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study aged 19 to 70 years who were free of cancer at study baseline (1992-2000) and were followed up to 31 September 2010. The model was validated in a sample comprising 74,403 participants selected among five EPIC centres. Over a median follow-up time of 15 years, there were 3645 and 981 colorectal cancer cases in the derivation and validation samples, respectively. Variable selection algorithms in Cox proportional hazard regression and random survival forest (RSF) were used to identify the best predictors among plausible predictor variables. Measures of discrimination and calibration were calculated in derivation and validation samples. To facilitate model communication, a nomogram and a web-based application were developed.

resultsThe final selection model included age, waist circumference, height, smoking, alcohol consumption, physical activity, vegetables, dairy products, processed meat, and sugar and confectionary. The risk score demonstrated good discrimination overall and in sex-specific models. Harrell's C-index was 0.710 in the derivation cohort and 0.714 in the validation cohort. The model was well calibrated and showed strong agreement between predicted and observed risk. Random survival forest analysis suggested high model robustness. Beyond age, lifestyle data led to improved model performance overall (continuous net reclassification improvement = 0.307 (95% CI 0.264-0.352)), and especially for young individuals below 45 years (continuous net reclassification improvement = 0.364 (95% CI 0.084-0.575)).

conclusionsLiFeCRC score based on age and lifestyle data accurately identifies individuals at risk for incident colorectal cancer in European populations and could contribute to improved prevention through motivating lifestyle change at an individual level.

Indexed as

Colorectal NeoplasmsDietLife StyleNutritional StatusCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesRisk AssessmentRisk FactorsCancer preventionColorectal cancerLifestyle behaviourRisk predictionRisk screening

Identifiers

PMID33390155
PMCPMC7780676
OpenAlexW3119715464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.